Serum levels of the soluble interleukin-2 receptor in vitiligo patients in UAE.
OBJECTIVE
To determine serum level of slL-2 receptor in patients with vitiligo in a population in Al Ain, UAE.


METHODS
This is a prospective, descriptive, hospital based study.


METHODS
Al Ain Medical District, Al Ain Hospital, UAE.


METHODS
Vitiligo patients seen at Al Ain hospital in 2003.


RESULTS
The study was based on 32 patients. The sample consisted 21 males and 11 females. 15 healthy individuals were selected as control group. Serum level of slL-2R were significantly higher in vitiligo patient (112 +/- 129.2) than in healthy control (61.1 +/- 44.3 Pmol/L) P < 0.0001. Patient with short duration of the disease shows higher the serum level slL-2R.


CONCLUSIONS
slL-2R showed significant difference between vitiligo patients and control.
Galadari
I
I
UAE University, Al Ain.
D000328:Adult; D004797:Enzyme-Linked Immunosorbent Assay; D000939:Epitopes / Q000276:immunology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015375:Receptors, Interleukin-2 / Q000097:blood*; D012995:Solubility; D014479:United Arab Emirates / Q000453:epidemiology; D014820:Vitiligo / Q000097:blood* / Q000453:epidemiology / Q000276:immunology
D000939:Epitopes; D015375:Receptors, Interleukin-2